Press Release

The largest neuromuscular clinic in Connecticut continues to grow

NEW BRITAIN, Conn. (August 18, 2009) – Effective Sept. 1, 2009, the Muscular Dystrophy Association (MDA) Pediatric Clinic Program will move from Connecticut Children’s Medical Center in Hartford to Hospital for Special Care in New Britain. Under the direction of Charles Whitaker, M.D., and Kevin Felice, D.O., the clinic will become a distinct part of the outpatient neuromuscular program at Hospital for Special Care (HSC).

"The Pediatric Clinic Program is a significant milestone for the neuromuscular center at Hospital for Special Care as we continue to build our resources and services as a best-in-class regional center," said co-director of Hospital for Special Care’s Neuromuscular/ALS center, Dr. Kevin Felice. "We are looking forward to welcoming these children and their families."

Currently, there are 102 children under the age of 18 eligible to attend the new clinic. It is anticipated that almost all of the existing 102 patients will transfer to the Hospital for Special Care clinic. Since they will be new patients at HSC’s neuromuscular center, their first visits will be evaluations for both physician and therapies as appropriate. Patients also will have access to a pediatric nurse, social worker, and dietician as needed.

According to Dr. Felice, HSC is preparing a welcoming package to assist patients, and there will be no interruption in services or care as the transition occurs. Additionally, full patient records will come with the patient when the clinic is moved to Hospital for Special Care. HSC will then coordinate primary care and specialists through the patient’s existing care providers.

The neuromuscular center at Hospital for Special Care has grown into the largest and most specialized clinic in the state. The types of conditions seen in the clinic include all neuromuscular disorders covered by the Muscular Dystrophy Association including muscular dystrophy, spinal muscular atrophy, Charcot-Marie-Tooth neuropathies, as well as amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MND).